deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT02155673

A Phase 2 Extension Study of Study GCS-100-CS-4002

Sponsor: La Jolla Pharmaceutical Company

Conditions Chronic Kidney Disease
Interventions GCS-100
Updated 6 times since 2017 Last updated: Dec 22, 2016 Started: Jan 31, 2014 Primary completion: May 31, 2016 Completion: Jun 30, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02155673, this PHASE2 trial focuses on Chronic Kidney Disease and remains completed. Sponsored by La Jolla Pharmaceutical Company, it has been updated 6 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2

    First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • La Jolla Pharmaceutical Company
Data source: La Jolla Pharmaceutical Company

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations